Lupin Methodological Note

On Disclosure of Payments and other Transfers of Values (TOV) to patient organisations.

1. Rationale

Lupin Healthcare (UK) Ltd “Lupin” is committed to working in an open and transparent way with patient Organisations, in order to better serve the needs of patients. We are working in collaboration with the Association of the British Pharmaceutical Industry (ABPI) in order to make sure that we continue to set high standards of ethical interaction between Lupin Healthcare (UK) Ltd and patient organisations within the UK.

2. Reporting Period

This data pertains to payments corresponding directly or indirectly from Lupin Healthcare (UK) Ltd To patient organisations which took place from 1st January 2019 to 31st December 2019.

3. Financial considerations

All transactions have been correctly accounted for, for both VAT and corporation tax purposes. All company transactions (whether subject to the disclosure of transfer of value or not) are reviewed as part of our annual financial and tax audit procedures. All amounts shown are exclusive of VAT.

4. Criteria for Inclusion/Exclusion

The disclosures include no more than is required by the ABPI Code. Information declared includes transfers of values that have been made. Transfers of value are declared according to the year in which the payment (transfer of value) took place. If an activity took place in this reporting period but was paid in 2020, it will be included in the year the transfer of value (payment) took place.

Cross border engagement: No cross border TOV took place

Non-monetary transfers of value: Disclosure of non-monetary transfers of value is made at the equivalent value in monetary terms.

Multi-year contracts: No multi-year contracts took place for the reporting period. 

5. Management of recipients’ queries

Lupin has an email address provided which is responsible for any transfer of value queries.

Any questions on the content here should be referred to information@lupin.com